Streamline Health Solutions, Inc. (STRM)
USD 1.9
(-6.95%)
USD 1.9
(-6.95%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -18.69 Million USD | -64.31% |
| 2022 | -11.37 Million USD | -64.51% |
| 2021 | -6.91 Million USD | -44.13% |
| 2020 | -4.79 Million USD | -67.62% |
| 2019 | -2.86 Million USD | 51.18% |
| 2018 | -5.86 Million USD | -89.24% |
| 2017 | -3.09 Million USD | 39.96% |
| 2016 | -5.16 Million USD | -20.31% |
| 2015 | -4.29 Million USD | 64.28% |
| 2014 | -12.01 Million USD | -2.51% |
| 2013 | -11.71 Million USD | -117.84% |
| 2012 | -5.37 Million USD | -42876.59% |
| 2011 | 12.57 Thousand USD | 100.43% |
| 2010 | -2.95 Million USD | -329.07% |
| 2009 | 1.28 Million USD | 193.68% |
| 2008 | -1.37 Million USD | -86.93% |
| 2007 | -735.56 Thousand USD | -862.55% |
| 2006 | 96.46 Thousand USD | -96.22% |
| 2005 | 2.55 Million USD | 357.45% |
| 2004 | 557.67 Thousand USD | -45.28% |
| 2003 | 1.01 Million USD | 0.71% |
| 2002 | 1.01 Million USD | 381.09% |
| 2001 | 210.36 Thousand USD | 906.84% |
| 2000 | 20.89 Thousand USD | 100.65% |
| 1999 | -3.2 Million USD | 70.64% |
| 1998 | -10.9 Million USD | 14.17% |
| 1997 | -12.7 Million USD | -170.21% |
| 1996 | -4.7 Million USD | -1466.67% |
| 1995 | -300 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -2.73 Million USD | -99.93% |
| 2024 Q2 | -2.8 Million USD | -2.34% |
| 2023 FY | -18.69 Million USD | -64.31% |
| 2023 Q4 | -1.37 Million USD | 88.5% |
| 2023 Q3 | -11.91 Million USD | -373.6% |
| 2023 Q2 | -2.51 Million USD | 13.31% |
| 2023 Q1 | -2.9 Million USD | -32.95% |
| 2022 FY | -11.37 Million USD | -64.51% |
| 2022 Q2 | -3.27 Million USD | -17.4% |
| 2022 Q1 | -2.78 Million USD | -9190.0% |
| 2022 Q3 | -3.13 Million USD | 4.1% |
| 2022 Q4 | -2.18 Million USD | 30.47% |
| 2021 FY | -6.91 Million USD | -44.13% |
| 2021 Q1 | -2.14 Million USD | -80.45% |
| 2021 Q3 | -4.31 Million USD | -7083.33% |
| 2021 Q2 | -60 Thousand USD | 97.2% |
| 2021 Q4 | -30 Thousand USD | 99.3% |
| 2020 Q3 | -1.05 Million USD | 7.05% |
| 2020 FY | -4.79 Million USD | -67.62% |
| 2020 Q1 | 3.67 Million USD | 252.79% |
| 2020 Q2 | -1.13 Million USD | -130.9% |
| 2020 Q4 | -1.18 Million USD | -12.51% |
| 2019 Q1 | 313 Thousand USD | 110.11% |
| 2019 Q3 | -164 Thousand USD | 73.03% |
| 2019 Q2 | -608 Thousand USD | -294.25% |
| 2019 FY | -2.86 Million USD | 51.18% |
| 2019 Q4 | -2.4 Million USD | -1365.85% |
| 2018 Q2 | -1.52 Million USD | -167.66% |
| 2018 FY | -5.86 Million USD | -89.24% |
| 2018 Q4 | -3.09 Million USD | -356.29% |
| 2018 Q3 | -678.51 Thousand USD | 55.43% |
| 2018 Q1 | -568.69 Thousand USD | -1601.71% |
| 2017 Q3 | 3489.00 USD | 100.32% |
| 2017 Q2 | -1.09 Million USD | 46.24% |
| 2017 Q4 | 37.87 Thousand USD | 985.41% |
| 2017 FY | -3.09 Million USD | 39.96% |
| 2017 Q1 | -2.04 Million USD | -100.41% |
| 2016 Q3 | -1.93 Million USD | -162.9% |
| 2016 Q1 | -1.47 Million USD | -5.3% |
| 2016 Q2 | -734.3 Thousand USD | 50.3% |
| 2016 Q4 | -1.01 Million USD | 47.21% |
| 2016 FY | -5.16 Million USD | -20.31% |
| 2015 Q3 | -456.66 Thousand USD | 19.06% |
| 2015 Q2 | -564.17 Thousand USD | 69.77% |
| 2015 FY | -4.29 Million USD | 64.28% |
| 2015 Q4 | -1.4 Million USD | -207.28% |
| 2015 Q1 | -1.86 Million USD | 61.2% |
| 2014 Q3 | -2.25 Million USD | 0.85% |
| 2014 Q1 | -2.67 Million USD | -37.22% |
| 2014 FY | -12.01 Million USD | -2.51% |
| 2014 Q2 | -2.27 Million USD | 14.83% |
| 2014 Q4 | -4.8 Million USD | -113.23% |
| 2013 Q4 | -1.94 Million USD | 68.76% |
| 2013 FY | -11.71 Million USD | -117.84% |
| 2013 Q3 | -6.23 Million USD | -652.52% |
| 2013 Q2 | -828.2 Thousand USD | 69.44% |
| 2013 Q1 | -2.7 Million USD | 65.29% |
| 2012 Q2 | -463.26 Thousand USD | -194.23% |
| 2012 Q3 | 2.39 Million USD | 617.98% |
| 2012 Q4 | -7.8 Million USD | -425.33% |
| 2012 FY | -5.37 Million USD | -42876.59% |
| 2012 Q1 | 491.62 Thousand USD | 10769.51% |
| 2011 Q4 | 4523.00 USD | -98.47% |
| 2011 FY | 12.57 Thousand USD | 100.43% |
| 2011 Q3 | 295.76 Thousand USD | 4359.92% |
| 2011 Q2 | -6943.00 USD | 97.53% |
| 2011 Q1 | -280.77 Thousand USD | 84.34% |
| 2010 Q2 | -75.93 Thousand USD | 93.54% |
| 2010 Q3 | 94.57 Thousand USD | 224.54% |
| 2010 Q4 | -1.79 Million USD | -1995.69% |
| 2010 FY | -2.95 Million USD | -329.07% |
| 2010 Q1 | -1.17 Million USD | -174.2% |
| 2009 Q4 | 1.58 Million USD | 636.05% |
| 2009 Q3 | -295.77 Thousand USD | -1547.84% |
| 2009 Q2 | -17.94 Thousand USD | -209.84% |
| 2009 FY | 1.28 Million USD | 193.68% |
| 2009 Q1 | 16.34 Thousand USD | 111.2% |
| 2008 Q1 | -814.62 Thousand USD | -205.0% |
| 2008 FY | -1.37 Million USD | -86.93% |
| 2008 Q2 | -428.99 Thousand USD | 47.34% |
| 2008 Q4 | -145.93 Thousand USD | -1101.26% |
| 2008 Q3 | 14.57 Thousand USD | 103.4% |
| 2007 FY | -735.56 Thousand USD | -862.55% |
| 2007 Q4 | 775.82 Thousand USD | 23911.85% |
| 2007 Q3 | 3231.00 USD | 100.3% |
| 2007 Q2 | -1.07 Million USD | -141.66% |
| 2007 Q1 | -443.31 Thousand USD | -249.79% |
| 2006 Q2 | 214.72 Thousand USD | 368.82% |
| 2006 FY | 96.46 Thousand USD | -96.22% |
| 2006 Q4 | 295.96 Thousand USD | 188.52% |
| 2006 Q3 | -334.35 Thousand USD | -255.71% |
| 2006 Q1 | -79.87 Thousand USD | -102.89% |
| 2005 Q3 | -454.46 Thousand USD | -187.52% |
| 2005 Q2 | 519.26 Thousand USD | 287.79% |
| 2005 FY | 2.55 Million USD | 357.45% |
| 2005 Q1 | -276.51 Thousand USD | -117.31% |
| 2005 Q4 | 2.76 Million USD | 707.92% |
| 2004 Q1 | -421.06 Thousand USD | -142.12% |
| 2004 Q3 | -156.4 Thousand USD | 66.17% |
| 2004 Q4 | 1.59 Million USD | 1121.39% |
| 2004 Q2 | -462.32 Thousand USD | -9.8% |
| 2004 FY | 557.67 Thousand USD | -45.28% |
| 2003 Q1 | -675.79 Thousand USD | -247.02% |
| 2003 Q4 | 999.7 Thousand USD | 107.56% |
| 2003 Q3 | 481.65 Thousand USD | 125.5% |
| 2003 Q2 | 213.59 Thousand USD | 131.61% |
| 2003 FY | 1.01 Million USD | 0.71% |
| 2002 Q2 | 201.63 Thousand USD | 105.18% |
| 2002 Q1 | 98.26 Thousand USD | -45.51% |
| 2002 Q3 | 252.43 Thousand USD | 25.2% |
| 2002 Q4 | 459.67 Thousand USD | 82.09% |
| 2002 FY | 1.01 Million USD | 381.09% |
| 2001 Q1 | 101.54 Thousand USD | -66.77% |
| 2001 FY | 210.36 Thousand USD | 906.84% |
| 2001 Q3 | 498.25 Thousand USD | 187.45% |
| 2001 Q2 | -569.77 Thousand USD | -661.13% |
| 2001 Q4 | 180.34 Thousand USD | -63.81% |
| 2000 Q4 | 305.53 Thousand USD | 676.38% |
| 2000 FY | 20.89 Thousand USD | 100.65% |
| 2000 Q1 | 314.82 Thousand USD | -21.29% |
| 2000 Q3 | 39.35 Thousand USD | 106.16% |
| 2000 Q2 | -638.82 Thousand USD | -302.91% |
| 1999 Q2 | -1.6 Million USD | 0.0% |
| 1999 Q1 | -1.6 Million USD | 40.74% |
| 1999 FY | -3.2 Million USD | 70.64% |
| 1999 Q4 | 400 Thousand USD | 180.0% |
| 1999 Q3 | -500 Thousand USD | 68.75% |
| 1998 Q3 | -2.1 Million USD | 27.59% |
| 1998 Q2 | -2.9 Million USD | 6.45% |
| 1998 Q1 | -3.1 Million USD | 16.22% |
| 1998 FY | -10.9 Million USD | 14.17% |
| 1998 Q4 | -2.7 Million USD | -28.57% |
| 1997 Q4 | -3.7 Million USD | -37.04% |
| 1997 Q1 | -2.8 Million USD | -7.69% |
| 1997 FY | -12.7 Million USD | -170.21% |
| 1997 Q3 | -2.7 Million USD | 22.86% |
| 1997 Q2 | -3.5 Million USD | -25.0% |
| 1996 Q1 | -800 Thousand USD | -260.0% |
| 1996 FY | -4.7 Million USD | -1466.67% |
| 1996 Q3 | -1.2 Million USD | -1100.0% |
| 1996 Q4 | -2.6 Million USD | -116.67% |
| 1996 Q2 | -100 Thousand USD | 87.5% |
| 1995 Q4 | 500 Thousand USD | 266.67% |
| 1995 Q2 | -100 Thousand USD | 75.0% |
| 1995 Q3 | -300 Thousand USD | -200.0% |
| 1995 FY | -300 Thousand USD | 0.0% |
| 1995 Q1 | -400 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CareCloud, Inc. | -48.67 Million USD | 61.587% |
| Augmedix, Inc. | -19.17 Million USD | 2.472% |
| BrightSpring Health Services, Inc. Common Stock | -154.6 Million USD | 87.906% |
| CareCloud, Inc. | -48.67 Million USD | 61.587% |
| HealthEquity, Inc. | 55.71 Million USD | 133.56% |
| iCoreConnect Inc. | -15.55 Million USD | -20.225% |
| Inovalon Holdings, Inc. | 22.57 Million USD | 182.807% |
| Nutex Health, Inc. | -45.78 Million USD | 59.165% |
| Omnicell, Inc. | -20.37 Million USD | 8.218% |
| OneMedNet Corporation | -23.2 Million USD | 19.428% |
| Progyny, Inc. | 62.03 Million USD | 130.138% |
| Renalytix Plc | -33.45 Million USD | 44.115% |
| Schrödinger, Inc. | 40.72 Million USD | 145.916% |
| Simulations Plus, Inc. | 9.95 Million USD | 287.834% |
| SOPHiA GENETICS SA | -78.98 Million USD | 76.327% |
| Ontrak, Inc. | -27.92 Million USD | 33.034% |
| GE HealthCare Technologies Inc. | 1.56 Billion USD | 101.192% |
| Sharecare, Inc. | -128.49 Million USD | 85.45% |
| Aclarion, Inc. | -4.91 Million USD | -280.688% |
| CareMax, Inc. | -683.34 Million USD | 97.264% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.35 Million USD | -249.094% |
| Forian Inc. | 11.1 Million USD | 268.34% |
| Bullfrog AI Holdings, Inc. Warrants | -5.35 Million USD | -249.094% |
| HeartBeam, Inc. | -14.63 Million USD | -27.72% |
| GeneDx Holdings Corp. | -175.76 Million USD | 89.363% |
| SCWorx Corp. | -3.98 Million USD | -369.639% |
| Minerva Surgical, Inc. | -34.11 Million USD | 45.189% |
| Definitive Healthcare Corp. | -202.38 Million USD | 90.762% |
| 10x Genomics, Inc. | -255.09 Million USD | 92.671% |
| Zhongchao Inc. | -11.33 Million USD | -64.936% |
| Accolade, Inc. | -99.8 Million USD | 81.266% |
| MSP Recovery, Inc. | -56.34 Million USD | 66.819% |
| R1 RCM Inc. | 3.3 Million USD | 666.576% |
| Spok Holdings, Inc. | 15.66 Million USD | 219.348% |
| Privia Health Group, Inc. | 23.07 Million USD | 181.013% |
| EUDA Health Holdings Limited | -10.03 Million USD | -86.235% |
| TruBridge, Inc. | -45.78 Million USD | 59.167% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | -154.6 Million USD | 87.906% |
| Sharecare, Inc. | -128.49 Million USD | 85.45% |
| Health Catalyst, Inc. | -118.14 Million USD | 84.175% |
| GoodRx Holdings, Inc. | -8.86 Million USD | -110.837% |
| Premier, Inc. | 119.54 Million USD | 115.64% |
| HealthStream, Inc. | 15.21 Million USD | 222.901% |
| Certara, Inc. | -55.35 Million USD | 66.225% |
| GeneDx Holdings Corp. | -175.76 Million USD | 89.363% |
| Ontrak, Inc. | -27.92 Million USD | 33.034% |
| SHL Telemedicine Ltd. | -7.05 Million USD | -164.98% |
| CareCloud, Inc. | -48.67 Million USD | 61.587% |
| EUDA Health Holdings Limited | -10.03 Million USD | -86.235% |
| HeartBeam, Inc. | -14.63 Million USD | -27.72% |
| Mangoceuticals, Inc. | -9.21 Million USD | -102.954% |
| CareMax, Inc. | -683.34 Million USD | 97.264% |
| Healthcare Triangle, Inc. | -12.33 Million USD | -51.528% |
| National Research Corporation | 30.97 Million USD | 160.369% |
| Aclarion, Inc. | -4.91 Million USD | -280.688% |
| OptimizeRx Corporation | -17.56 Million USD | -6.439% |